Company Profiles

driven by the PitchBook Platform

Advanced Cancer Therapeutics

Description

Developer of cancer therapeutics. The company engages in the discovery, development, manufacturing, and commercialization of cancer therapeutics. It develops a pipeline of anti-cancer products, including MIF, a macrophage migration inhibitory factor; PU27, a synthetic oligonucleotide that is used as an anticancer compound; PFKFB3, a small molecule compound; CK37, a small molecule that inhibits cell proliferation, choline kinase enzymatic activity, and tumor growth; and a vaccine for human papilloma virus, which is caused for cervical cancer.

2007

Founded

PRIVATE

Status

Grant

Latest Deal Type

$158k

Latest Deal Amount

$10.7M

Total Amount Raised

4

Investors

Description

Developer of cancer therapeutics. The company engages in the discovery, development, manufacturing, and commercialization of cancer therapeutics. It develops a pipeline of anti-cancer products, including MIF, a macrophage migration inhibitory factor; PU27, a synthetic oligonucleotide that is used as an anticancer compound; PFKFB3, a small molecule compound; CK37, a small molecule that inhibits cell proliferation, choline kinase enzymatic activity, and tumor growth; and a vaccine for human papilloma virus, which is caused for cervical cancer.

Website:

www.advancedcancertherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

333 East Main Street Suite 280 Louisville, KY 40202United States +1 (502) 589-6404
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Advanced Cancer Therapeutics's full profile, request a free trial.

Advanced Cancer Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Advanced Cancer Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
CommonWealth Seed CapitalNot-For-Profit Venture CapitalMinority000 0000000 0000
Kentucky Cabinet for Economic DevelopmentBusiness Development Company000 0000000 0000
National Cancer InstituteGovernment000 0000000 0000
Yearling ManagementVenture CapitalMinority000 0000000 0000
CommonWealth Seed Capital Not-For-Profit Venture Capital
Kentucky Cabinet for Economic Development Business Development Company
National Cancer Institute Government
Yearling Management Venture Capital

Advanced Cancer Therapeutics Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Randy RiggsChief Executive Officer & President
Gilles Tapolsky Ph.DChief Scientific Officer
Donald MillerCo-Founder & Board Member
Dale Boden IIChairman & Co-Founder
Tyree WilburnBoard Member & Co-Founder
Randy Riggs Chief Executive Officer & President
Gilles Tapolsky Ph.D Chief Scientific Officer
Donald Miller Co-Founder & Board Member
Dale Boden II Chairman & Co-Founder
Tyree Wilburn Board Member & Co-Founder

Advanced Cancer Therapeutics Board Members (6)

NameRepresentingRoleSinceContact
Info
Dale Boden IISelfChairman & Co-Founder000 0000
Donald MillerAdvanced Cancer TherapeuticsCo-Founder & Board Member000 0000
James Ramsey Ph.DSelfBoard Member000 0000
Robert Rounsavall IIIAdvanced Cancer TherapeuticsBoard Member000 0000
Ted Steinbock MDSelfBoard Member000 0000
Dale Boden II Chairman & Co-Founder Self
Donald Miller Co-Founder & Board Member Advanced Cancer Therapeutics
James Ramsey Ph.D Board Member Self
Robert Rounsavall III Board Member Advanced Cancer Therapeutics
Ted Steinbock MD Board Member Self
Request full access to PitchBook